. The annual production of VA in Japan was reported to amount to 588,786 tons in 2000 2) . Workers and consumers are at health risk to be exposed to VA in its manufacturing and using processes and in uses of its commercial emulsion products, respectively. VA has been reported to cause an irritation effect on the respiratory system of workers 3) and an excess risk for cancer of the respiratory system in a synthetic chemicals plant 4) . Rodent bioassay studies available for cancer risk assessment of workers exposed to VA have been limited [5] [6] [7] [8] [9] . Lijinsky and Reuber 5) reported induction of both thyroid and uterine tumors in the Fischer rat given VA-formulated drinking water for two years. Bogdanffy et al. 6) reported a significantly increased incidence of nasal tumors in Sprague-Dawley (SD) rats exposed to VA by 2-yr inhalation but not in ICR mice, but they 7) showed no treatment-related increase in tumor incidence of the SD rats administered VA in drinking water for in utero and subsequent lifetime. Maltoni et al. 8) and Minardi et al. 9) reported induction of carcinomas at multiple sites in Swiss mice and SD rats administered VA-formulated drinking water for two years, respectively. In vitro mutagenesis assays revealed that while VA was negative for mutagenicity in assays with prokaryotes 10) , the compound was clastogenic in in vitro assays with cultured human lymphocytes and Chinese hamster ovary cells with or without enzymatic activation 11, 12) . VA has been evaluated as a possible human carcinogen (Group 2B) by the International Agency for Research on Cancer (IARC) 1) and the Japan Society for Occupational Health (JSOH) 13) , as a confirmed animal carcinogen with unknown relevance to human (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH) 14, 15) , and as being suspected of having carcinogenic potential (3B) in Germany 16) . The present study was intended to better characterize carcinogenicity and chronic toxicity of VA in a bioassay study of rodents and to provide dose-response data for cancer risk assessment of VA-exposed workers. We examined the carcinogenicity and chronic toxicity of VA in male and female Crj:BDF 1 mice and F344/DuCrj rats orally administered VA in drinking water for 104 wk. Classification of VA for the carcinogenic potential and causative factors for VA-induced carcinogenicity were discussed in the light of the present findings as well as the literature.
Materials and Methods
The present study was conducted in accordance with the Principles of Good Laboratory Practice (GLP) 17) and the Guideline for Testing of Chemicals 453 (Combined Chronic Toxicity/Carcinogenicity Studies) 18) of the Organisation for Economic Co-operation and Development (OECD).
Chemical: VA (reagent grade, more than 98.0 % purity) was obtained in five different lots from Wako Pure Chemical Industries Ltd (Osaka, Japan). The test substance was stored in a dark vessel at room temperature. Each lot of the test substance was analyzed for purity and stability by both mass spectrometry and infrared spectrometry before and at the end of its use.
Preparation of drinking water containing VA and its stability: VA was dissolved in deionized water to a target concentration of 0 (control), 400, 2,000 or 10,000 ppm (g/g). The stock VA solution of each target concentration was prepared in a stainless steel jug of 7 liters for mice and 36 liters for rats, and dispensed by means of dark glass bottles equipped with a glass sipper tube. A drinking bottle filled with a full volume (200 ml) of the VAformulated drinking water was used for both mice and rats, in order to prevent a decrease in the VA concentration due to evaporation of VA from the bottle. The VAformulated drinking water was prepared twice a wk. Stability of VA in the drinking water was examined 4 d after preparation of the VA-formulated drinking water. The concentrations of VA and acetic acid in the drinking water were determined with a gas chromatograph (Hewlett Packard HP5890A, USA) and a liquid chromatograph-mass spectrometer (Thermoquest TSQ-7000, USA), respectively. The pH of the drinking water was also measured.
Animals: Male and female Crj:BDF 1 mice and F344/ DuCrj rats were purchased from Charles River Japan Inc. (Crj:BDF 1 mice: Shiga, Japan and F344/DuCrj rats: Kanagawa, Japan) at 4 wk of age. The animals were quarantined and acclimated for 2 wk, and divided by stratified randomization into 4 weight-matched groups, each consisting of 50 mice and 50 rats of each sex. Oral administration of VA-formulated drinking water to the animals was started at the age of 6 wk.
The animals were housed individually in stainless steel wire-mesh hanging cages (112W × 212D × 120H mm for mice and 170W × 294D × 176H mm for rats) under controlled environmental conditions (temperature of 24 ± 2°C and a relative humidity of 55 ± 10%, with 15-17 room air changes/h). Fluorescent lighting was controlled automatically to provide a 12-h light/dark cycle. All animals were given ad libitum diet (CRF-1, Oriental Yeast Co. Ltd., Tokyo, Japan) and the assigned drinking water.
Experimental design, and clinical observations and analysis: Groups of 50 mice and 50 rats of each sex were given drinking water containing 0 ppm (control), 400 ppm, 2,000 ppm or 10,000 ppm for 104 wk. Control animals received deionized water only. The animals were observed daily for clinical signs and mortality. Body weight and food and water consumption were measured weekly for the first 13 wk of the 2-yr administration period and every 4 wk thereafter. Animals which were found dead, in a moribund state or survived to the end of 2-yr administration period received complete necropsy. Urinary, hematological and blood biochemical parameters of all surviving animals were measured in urine samples collected at the last 104th wk and in blood samples taken from the abdominal aorta under etherization after overnight fasting at the end of 2-yr administration period. The urinary parameters including pH, protein, glucose, ketone bodies, bilirubin (rats only), occult blood, and urobilinogen were examined with Urolabstix (Diagnostic Diutsior, Bayer, Elkhart, Germany). The hematological and blood biochemical parameters specified in the OECD test guidelines 18) were measured in the present study.
Macroscopic and histopathological examinations:
Organs were examined macroscopically, and the tissues specified in the OECD test guidelines 18) were examined for histopathology. Those tissues were fixed in 10% neutral buffered formalin, and embedded in paraffin by the routine procedures. Tissue sections 5 µm thick were prepared and stained with hematoxylin and eosin. The oral cavity was examined histopathologically at six different levels as shown in Fig. 1 . The maxilla and mandible were decalcified with a 5% formic acidformalin solution. Then the maxilla was trimmed with the nasal cavity in three cross sections at the levels of the posterior edge of the upper incisor teeth (Level I), the incisive papilla (Level II) and the anterior edge of the upper molar teeth (Level III). The mandible was trimmed in three cross sections at the levels of the posterior edge of the lower incisor teeth (Level IV), the anterior edge of the lower molar teeth (Level VI) and the middle point between Levels IV and VI (Level V).
The neoplastic and pre-neoplastic lesions were diagnosed with reference to the IARC monograph 19) , the Standardized System of Nomenclature and Diagnostics Criteria 20) and the Textbook of Oral Pathology 21) .
Statistical analysis: Incidences of non-neoplastic lesions and urinary data were analyzed by chi-square test. The incidence of neoplastic lesions was statistically analyzed by Peto's test 22) and Fisher's exact test. Body weight, food and water consumptions, and hematological and blood biochemical parameters were analyzed by Dunnett's Test. The method for application of the statistical tests to those data was given in a previous paper 23) . A lower confidence limit of the benchmark dose yielding a response with 10% extra risk (BMDL 10 ) was calculated for combined incidences of squamous cell carcinomas and papillomas in the oral cavity. Estimated daily VA intakes per body weight of mice and rats were used a dose parameter. A software program of the BMDS Version 1.3.1 downloaded from US. EPA's NCEA Web site 24) was used in the present study. Either a multistage, Gamma, quantal quadratic, Weibull, linear (log) or polynomial model was selected, based on the goodnessof-fit p-value, the Akaike's Information Criterion (AIC) value and visual inspection of the model fitting the curve between the estimated VA intake/body weight and the incidence of the endpoint.
Results

Purity and stability of VA in drinking water
The VA concentrations in the drinking water measured 4 d after the preparation were found to decrease to 72-80% of the initial concentrations for rats and 86-96% for mice. The decrease in the VA concentration was attributed mainly to the loss due to vaporation of VA from the drinking bottle. The acetic acid concentration and the pH measured 4 d after the preparation were 9.2 ppm and pH 4.0 for the 400 ppm VA-formulated drinking water, 47 ppm and pH 4.2 for the 2,000 ppm water and 263 ppm and pH 3.6 for the 10,000 ppm water at the end of the 4-day administration period.
Mice study
Survival, body weight, food and water consumptions, clinical signs: In the 10,000 ppm group, 6 males and 4 females died of oral cavity tumor, 1 male died of esophagus tumor, 1 male and 2 females died of stomach tumor, and 1 male and 1 female died of larynx tumor. Those tumor deaths started to occur sporadically after a 1-yr elapse of the 2-yr administration period, but no significant difference in the survival rate was found between any VA-administered group of each sex (Table  1 ) and the respective control. The incidence of the oral cavity nodules (Fig. 2) significantly increased in the 10,000 ppm group of both sexes: three males after the 57th wk and five females after the 95th wk. Body weights of the 10,000 ppm males and females were significantly lower by 30 and 18%, respectively, than those of controls at the end of the 2-yr administration period (Table 1) . There was no significant difference in food consumption between any VA-administered group of each sex and the respective control (Table 1) . Water consumption was lower in the 10,000 ppm group of each sex than in the respective control, especially in the later period of the 2-yr administration. Daily VA intake per body weight, which was estimated by the bottle concentration of VA and the amount of water consumed, was found to increase proportionally with the increase in the VA concentration in the drinking water except for the 10,000 ppm group (Table 1) . The estimated VA intake per body weight was greater in female mice than in male mice at all the VA concentrations.
Organ weights and macroscopic findings: Statistically significant changes in the absolute and relative organ weights were observed in several organs of the 10,000 ppm-exposed males and females, but those changes were not associated with histopathological changes.
Mandibular nodules (Fig. 2 ) were observed in 3 males and 5 females of the 10,000 ppm group, whereas maxillary nodules were observed in 3 males and one female of the 10,000 ppm group.
Hematology, blood chemistry and urinalysis: Neither a consistent nor VA treatment-related effect on the parameters of hematology and blood chemistry was observed, although statistically significant changes occurred sporadically in several parameters.
Histopathological examinations: Incidences of squamous cell tumors in the oral cavity and forestomach of male and female mice and in the esophagus of male mice significantly increased in a VA treatment-related manner as indicated by Peto's test ( Table 2 ). The 10,000 ppm VA administration significantly increased the incidence of the squamous cell carcinomas in those organs (Table 2) . Besides, the squamous cell carcinomas were observed in the esophagus and larynx of the 10,000 ppm females, in the larynx of the 2,000 ppm females and in the larynx of the 10,000 ppm males. Although the incidences of squamous cell carcinomas in those organs were not statistically significant, they exceeded the range of the historical control data of the Japan Bioassay Research Center (Table 2) . Squamous cell papillomas were also observed in the oral cavity and forestomach of both 10,000 ppm males and females and in the esophagus of a 2,000 ppm female. The squamous cell papilloma was characterized by exophytic projection of the tumor tissue above the stratified squamous epithelium, which was composed of a central core of the tumor connective tissue covered with hyperplastic squamous cells having neither cellular nor structural atypia. In contrast, squamous cell tumors having either cellular or structural atypia were diagnosed as squamous cell carcinoma (Fig. 3) . Of those squamous cell carcinomas, 20 oral cavity carcinomas, 4 esophagus carcinomas and all 10 forestomach carcinomas were characterized by endophytic growth in which the tumor cells were proliferated inward into the subepithelial tissue. The endophytic growth type of squamous cell carcinomas, 14 oral cavity, 4 esophagus and 8 forestomach, had invasion of the tumor tissue into the muscle layer that was indicative of severe malignancy. Moreover, 5 male mice were found to bear squamons cell carcinomas in multiple organs. Six oral cavity squamous cell carcinomas and 2 forestomach squamous cell carcinomas were metastasized into the lungs, the pancreas, the liver, the kidneys, and the lymph nodes (Fig. 4) . Pre-neoplastic lesions were observed in the stratified squamous epithelium of the upper digestive tract, and were further classified into basal cell hyperplasia, squamous cell hyperplasia and epithelial dysplasia (Table  3 ). In the oral cavity, basal cell hyperplasia and the squamous cell hyperplasia occurred not only in the 10,000 ppm but also in the 2,000 ppm groups of both sexes, and the epithelial dysplasia increased markedly in the 10,000 ppm group of both sexes. The 10,000 ppm administration increased those three pre-neoplastic lesions in the esophagus, the forestomach and the larynx. Basal cell hyperplasia was characterized by multiplication of the basal cell layer, often protruding into the subepithelial tissue. Squamous cell hyperplasia was diagnosed as proliferation of the entire cell components of normal squamous epithelium. Squamous epithelium having either cellular or structural atypia was diagnosed as the epithelial dysplasia which was characterized by abnormally differentiated squamous layers and usually accompanied by thickening of the epithelium. As shown in Table 4 , mapping of the neoplastic and pre-neoplastic lesions in the oral cavity of male and female mice administered 10,000 ppm VA revealed that the incidence of those lesions was higher at Level V of the mandibular region than at any other Levels. It was also striking that more than 60% of male mice and 35% *: The value indicates the total number of animals bearing the lesions. The parenthesized value indicates number of animals having two or more lesions at different sites. The locations and levels are indicated in Fig. 1 .
of female mice had two or more pre-neoplastic lesions at different sites, whereas there was only one male mouse bearing a carcinoma and basal cell hyperplasia at different sites. One tongue squamous cell papilloma and one carcinoma were observed in the 10,000 ppm female group, but the incidence of those tumors neither significantly increased over the respective control nor exceeded the range of the historical control data. Five and two animals bearing squamous cell tumors in the 10,000 ppm group had atrophy of the salivary gland at Level V and Level II, respectively. Two and one animals bearing pre-neoplastic lesions also had salivary gland atrophy in the mandible at Levels IV and V, respectively. Other types of tumors were observed in the spleen, lungs, uterus and nasal cavity of the VA-administered groups, but the incidences of those tumors were not statistically different from those in the respective controls (Table 2) .
Rats study
Survival, body weight, food and water consumptions, clinical signs: In the 10,000 ppm group, two male rats died of oral cavity tumors in the 97th and 100th wk, but there was no statistical difference in the survival rate at the end of the 2-yr administration period between any VA-administered group of each sex and the respective control ( Table 1) . As a clinical sign, an oral cavity nodule appeared in a 400 ppm female after the 87th wk. Body weights of the 10,000 ppm males and females measured at the end of the 2-yr administration period were significantly lower by 8 and 10%, respectively, than those of the respective controls (Table 1) . No difference in food consumption was found between any VAadministered group of each sex and the respective control (Table 1) . Water consumption of the 10,000 ppm males and females decreased by 15% and 18%, respectively, compared to the corresponding controls throughout the experimental period. The estimated daily VA intake per body weight was found to increase with an increase in the VA concentration in the drinking water except for the 10,000 ppm group which exhibited only a 4.0 to 4.5-fold increase in the intake whereas the bottle VA concentration was increased by 5.0-fold. The estimated daily VA intake per body weight was greater in female rats than in male rats at all the VA concentrations. The daily VA intake per body weight of the rats was smaller by 2-to 2.4-fold than that of the mice. weights were observed in several organs of the 10,000 ppm-exposed males and females, but those changes were not associated with histopathological changes. The mandiblar nodule also occurred in 3 males in the 10,000 ppm group, and a female in the 400 ppm group. The maxillary nodule appeared only in a female in the 10,000 ppm group.
Organ weights and macroscopic findings: Statistically significant changes in the absolute and relative organ
Histopathological examinations: Squamous cell carcinomas and squamous cell papillomas were observed in the oral cavity and the esophagus, and their histological characteristics were the same as those observed in the mice. In males, squamous cell carcinomas and papillomas were seen in the oral cavity of five and two 10,000 ppm males, respectively. The incidence of oral cavity squamous cell carcinomas in the 10,000 ppm males was significantly higher than that in the control group, and increased in a VA treatment-related manner as indicated The value indicates the total number of animals bearing lesions. The parenthesized value indicates number of animals having two or more lesions at different sites. The locations and levels are indicated in Fig.1 .
by Peto's test. In females, squamous cell carcinomas were observed in the oral cavity of 3 rats and in the esophagus of 1 rat in the 10,000 ppm group, and the incidence of oral cavity and esophagus squamous cell carcinomas exceeded the range of the historical control data of our Institute (Table 5) . One oral cavity squamous cell carcinoma was also seen in the 2,000 ppm group and one in the 400 ppm female group. All the squamous cell carcinomas except two had endophytic growth which was characterized by proliferative invasion of the tumor tissue inward into the subepithelial tissue. Of those endophytic carcinomas, 2 oral cavity carcinomas in the 10,000 ppm males and 1 oral cavity and esophagus carcinoma each in the 10,000 ppm females had invasion of the tumor tissue into the muscle layer, indicative of severe malignancy (Fig. 5) . Pre-neoplastic lesions were observed in the stratified squamous epithelium of the upper digestive tract (Table  6 ). All the pre-neoplastic lesions occurred in the 10,000 ppm group except for the forestomach squamous cell hyperplasia in both a control and a 2,000 ppm male. Mapping of those neoplastic and pre-neoplastic lesions in the rat oral cavity of the 10,000 ppm group of both sexes is shown in Table 7 . It was striking that 4 squamous cell carcinomas out of 8 tumors tended to occur at Level VI, although neoplastic and pre-neoplastic lesions were distributed throughout the oral cavity. Focal basal cell hyperplasia was observed at two different sites in the oral cavity of a single animal ( Table 7) .
The uterine polyp and tumors in females as well as thyroid tumors in both males and females were observed, but the incidences of those tumors were not significantly higher than those in the corresponding controls.
Dose-response relationships for tumors in mice and rats
The combined incidence of squamous cell carcinomas and papillomas in the oral cavity of mice and rats of both sexes was plotted against the estimated daily VA intake per body weight but not against the drinking water level of VA, as shown in Figure 6 . The tumor incidence increased discernibly above the daily intake of 400 mg VA/kg/d. A BMDL 10 for the combined incidences of squamous cell carcinomas and papillomas in the oral cavity of mice and rats resulted in 477 mg/kg/d, based on a multistage model with an AIC value of 232 and a Pvalue greater than 0.09. The dose-response curve was shown in a multistage model.
Discussion
In the present study, it was found that oral administration of VA in drinking water for two years induced squamous cell carcinomas and papillomas and pre-neoplastic lesions in the upper digestive tract of mice and rats of both sexes. It was also found that incidences of those neoplastic and pre-neoplastic lesions significantly increased in a VA treatment-related manner in the oral cavity and forestomach of male and female mice and in the esophagus of male mice and in the oral cavity of male and female rats. Both the oral cavity tumor deaths of 10 mice and 2 rats and the oral cavity nodules of 8 mice as a clinical sign were found to increase after 1-yr of 10,000 ppm administration, indicating an exposure time lengthrelated increase in the oral cavity tumors. IARC 1) evaluated VA as being possibly carcinogenic to humans (Group 2B) in 1995, based on three different facts and the weight of evidence: first on inadequate evidence of cancer-epidemiological data, secondly on limited evidence that the increased incidence of nasal cavity tumors was found only in rats by inhalation 6) and thirdly on supportive evidence that VA was metabolized to acetaldehyde which exhibited sufficient evidence of carcinogenicity in experimental animals 25) . Therefore, the present findings would confirm the IARC's overall evaluation of VA-induced carcinogenicity by providing clear evidence that a dose-related increase in the incidence of malignant tumor, i.e. squamous cell carcinoma, occurred in the upper digestive tract of two rodent species of both sexes orally administered VA in drinking water for two years.
Previous studies 8, 9) did not show any histological characteristics of squamous cell carcinomas and papillomas in the oral cavity, esophagus and forestomach. The VA-induced squamous cell carcinomas found in the present study were characterized by a predominance of the endophytic growth type with either cellular or structural atypia. In particular, some of these endophytic squamous cell carcinomas exhibited invasion of the affected tissue into the muscle layer. Furthermore, the squamous cell carcinomas in the oral cavity and the forestomach of mice were metastasized to other organs, indicative of unequivocal malignancy.
In the present study, basal cell hyperplasia, squamous cell hyperplasia and epithelial dysplasia were observed in the stratified squamous epithelium of not only the esophagus and forestomach but also the oral cavity in both mice and rats. These pre-neoplastic lesions are known to have the potential to progress to squamous cell tumors 20, 26) . Maltoni et al. 8) and Minardi et al. 9) reported that the occurrence of squamous cell dysplasias in the esophagus and forestomach was closely associated with squamous cell carcinomas. Tanaka et al. 27) suggested that severe dysplasia was a direct precursor of the tongue squamous cell carcinoma induced by 4-nitroquinoline-1-oxide. Taking into consideration these three reports, the present findings of a histopathological similarity between the epithelial dysplasia accompanied by either structural or cellular atypia and the squamous cell carcinoma as well as the high incidences of the epithelial dysplasia and squamous cell carcinoma can be taken to indicate that epithelial dysplasia develops directly into the squamous cell carcinoma.
It was noteworthy that the squamous cell tumors and the pre-neoplastic lesions were observed more frequently in the oral cavity than in the other upper digestive tract organs in the VA-administered mice and rats, and that those proliferative lesions occurred predominantly in the caudal and exterior region of the mandible (Level V in mice and Level VI in rats). The oral cavity predominance of the tumors over the other upper digestive tract organs can be accounted for by a higher VA level of exposure of the oral cavity squamous epithelium than in the other upper digestive tract organs, because the VA-formulated drinking water first enters the oral cavity without dilution with mucous secretory fluid. The tumor predominance in the caudal and exterior region of the mandible may be causally related to the anatomical structure of this mandibular region which allows long retention of the VAformulated drinking water in the mouth, resulting in longer time exposure of the regional squamous epithelium to VA than the other regions. Nevertheless, the tumor predominance in the oral cavity and in the causal and exterior mandibular region is not compatible with the findings by Morris et al. 28) and by Bogdanffy et al. 6, 29, 30) Bogdanffy et al. 29, 30) proposed a mode-of-action hypothesis that intracellular, carboxylase-dependent metabolism of VA to acetic acid, a potent cytotoxicant, and acetaldehyde, a weak clastogen, was responsible for cell death and restorative cell proliferation leading to the development of the nasal cavity squamous cell tumors. Morris et al. 28) reported that VA hydrolytic activity of the dorsal interior region of the oral mucosa was 3.3-and 7.6-fold higher for rats and mice, respectively, than that of the ventral interior region, but the VA hydrolytic activity of the oral mucosa as a whole was 100-fold lower than that of the nasal cavity. Nevertheless, the caudal and exterior mandible (Levels V and VI) in which the neoplastic and pre-neoplastic lesions occurred predominantly in the present study exhibited lower VA hydrolytic activity than in the dorsal interior region of the oral cavity according to the study of Morris et al. 28) Although Bogdanffy et al. 6) demonstrated VA-induced squamous cell tumors and atrophy of the olfactory epithelium in the nasal cavity of rats exposed to VA by inhalation for two years, it was found in the present study that no degeneration, necrosis or atrophy was histopathologically observed in the oral cavity of mice and rats given VA-formulated water for two years. The present finding was consistent with the result reported by Valentine et al. 31) that the increased restorative cell p r o l i f e r a t i o n w a s n o t a c c o m p a n i e d b y a n y histopathological change in the oral cavity of mice and rats given VA-formulated drinking water for 92 d.
The present finding of VA-induced squamous cell carcinomas and papilloma in the upper digestive tract of mice and rats is in apparent contrast to the results from the VA-formulated drinking water studies by Bogdanffy et al. 7) and Lijinsky and Reuber 5) , but consistent with the results by Maltoni et al. 8) The difference and similarity in the VA-induced carcinogenicity between the results so far reported and the present findings appear to exist in a difference in the amount of daily VA intake. Indeed, a BMDL 10 value resulted in 477 mg/kg/d for the oral cavity squamous cell tumors as shown in Figure 6 . Judging from the dose-response curve, the estimated daily VA intakes employed by Lijinsky and Reuber 5) and Bogdanffy et al. 7) appear to be lower than a dose level enough to significantly increase the tumor incidence. In the study of Lijinsky and Reuber 5) , oral administration of the 1,000 ppm (40 g/kg for females and 25 g/kg for males during the 100-wk administration period) and 2,500 ppm water (100 g/kg for females and 62 g/kg for males) was estimated to correspond to 35 and 88 mg/kg/d for male rats and 57 and 143 mg/kg/d for female rats, respectively, on the daily intake basis. Bogdanffy et al. 7) reported that oral administration of drinking water containing 200, 1,000 and 5,000 ppm VA corresponded to 10, 47 and 202 mg/kg/d for male rats and 16, 76 and 302 mg/kg/d for female rats, respectively. In the study of Maltoni et al. 8) who reported positive induction of multiple site squamous cell carcinomas in Swiss mice, however, the daily VA intake of the 5,000 ppm-administered mice was estimated as 506 mg/kg/d for males and 533 mg/kg/d for females, assuming that the male and female Swiss mice consumed 4.3 g and 4.0 g of the 5,000 ppm VA-formulated drinking water, the same amounts consumed by the male and female Crj:BDF 1 mice used in the present study, respectively. Therefore, it can be inferred on the basis of the present findings as well as in the literature that longterm exposure of the oral cavity squamous epithelium to greater than 400-500 mg/kg/d induces the squamous cell carcinomas and papillomas.
In conclusion, the present findings of dose-related increases in the incidences of malignant and benign squamous cell tumors in the upper digestive tract of the two rodent species of both sexes orally administered VA in drinking water for two years would provide clear evidence of VA-induced animal carcinogenicity for the internationally accepted evaluation of chemical carcinogenicity for VA as a possible human carcinogen of 2B in IARC 1) and JSOH 13) .
